(Q30494709)

English

Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy (English)

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

0 references

1 reference

based on heuristic

inferred from title

Kevin R. Coombes

10

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Gordon B. Mills

13

object named as

Gordon B Mills

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Bryan T. Hennessy

14

object named as

Bryan T Hennessy

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

3

object named as

Blake Gilks

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

author name string

Mark S Carey

1

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Roshan Agarwal

2

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Kenneth Swenerton

4

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Steve Kalloger

5

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Jennifer Santos

6

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Zhenlin Ju

7

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Yiling Lu

8

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Fan Zhang

9

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Dianne Miller

11

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

David Huntsman

12

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

language of work or name

0 references

publication date

11 May 2010

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

16

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

10

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

2852-2860

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Gene expression profiling and prediction of clinical outcome in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Critical molecular abnormalities in high-grade serous carcinoma of the ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

First-line randomized trials: revisiting the Ptolemaic universe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Pharmacodynamic markers of perifosine efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Roles of Smad3 in TGF-beta signaling during carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Reversible Smad-dependent signaling between tumor suppression and oncogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

20 June 2018

Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Microarrays: retracing steps

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Non-parametric quantification of protein lysate arrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2877659

26 November 2018

SMAD3 regulates gonadal tumorigenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prognostic value of CA125 half-life and early normalization during chemotherapy in advanced ovarian tumors: results of a multicentric French study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian carcinoma: a multivariate analysis of prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20460476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-09-2502

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30494709&oldid=1986778710"